Effects of Aerobic Training Post-stroke
Effects of Aerobic Training on Physical Activity Levels and Sedentary Behavior in Subjects Post-stroke: a Randomized Controlled Trial
Physical activity level is an important determinant of quality of life in persons post-stroke. There is a lack of knowledge regarding the effects of aerobic training on physical activity levels in subjects post-stroke. Therefore, the primary objective will be to investigate the effects of aerobic treadmill training on physical activity levels and sedentary behavior in subjects post-stroke. The secondary aim will be to investigate the effects of the training on cardiorespiratory fitness, endurance, depression, mobility, quality of life, and participation.
A randomized controlled trial with blinded assessment will assign eligible participants to either: 1) aerobic treadmill training (experimental group, at 60-80% of heart rate reserve), or 2) overground walking (control group, below 40% of heart rate reserve). Both groups will receive 40-minute training sessions three times/week over 12-weeks, in groups of 2-4 participants, by a trained physiotherapist. Primary outcomes: physical activity levels and sedentary behavior (Multisensor SenseWear Mini® and Human Activity Profile). Secondary outcomes: cardiorespiratory fitness (peak oxygen uptake (VO2peak) and ventilatory threshold), endurance, depression, mobility, quality of life, and participation. The effects of the trainings will be analyzed from the collected data and intention-to-treat analysis. Between-groups differences will be measured by two-way ANOVA with repeated measures considering the baseline, post-training, and a 4-week follow-up.
The results of this trial will likely provide valuable new information about the effects of aerobic treadmill training in improving physical activity levels and sedentary behavior, through changes in cardiorespiratory fitness, for individuals following stroke.
調査の概要
詳細な説明
The sample size has been calculated considering the physical activity levels measured by the Human Activity Profile (HAP). The effect size has been derived from the study of Teixeira-Salmela et al. 1999, who performed aerobic training in addition to lower limbs resistance training, and home exercises with subjects with chronic stroke. The experimental group (n=6) showed an increase on HAP on average of 20±6.1 points after the intervention, and the control group (n=7) had an average reduction of 1.86±0.19 points. Considering a significance level of 5% and a desired power of 80%, 9 participants per group was found, or 18 participants in total. Assuming an expected dropout rate of 20%, a target of 22 participants in total was set (11 participants per group).
Statistical analyses: A code will be given to each participant. Two independent examiners, blinded to the group allocation, will perform data entry, and verify missing or apparently wrong values. Original paper forms will be kept in a secure place. Electronic files will be available only to the research team. An independent examiner, blinded to the group allocation, will perform the statistical analysis by SPSS (SPSS Inc., Chicago, IL, USA). Descriptive statistics will be performed for all outcome variables. Baseline variables will be compared between groups using independent Student's t-tests, to investigate differences among the groups regarding the clinical-demographical characteristics. If differences between the groups at baseline exist, analysis of covariance will be used to eliminate the influence of extraneous factors. The effects of the interventions will be analyzed from the collected data and the intention-to-treat analysis. Data from the last available assessment will be considered as the values of missed sessions. Between-groups differences will be measured with two-way ANOVA with repeated measures considering the baseline, post-training, and follow-up measures. Level of significance will be set at 0.05 and adjusted for multiple comparisons. Normality and equality of variance will also be analyzed to ensure correct use of parametric data. Study results will be spread regardless of the magnitude and direction of the effects.
研究の種類
入学 (実際)
段階
- フェーズ 4
連絡先と場所
研究場所
-
-
Minas Gerais
-
Belo Horizonte、Minas Gerais、ブラジル
- Universidade Federal de Minas Gerais
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- ≥ 20years of age;
- diagnosis of stroke (>6months);
- sedentary or insufficiently active;
- have a writing medical permission to participate in the training program.
Exclusion Criteria:
- cognitive impairment (Mini-Mental Status Examination score: illiterate 13 points; elementary and middle school 18 points; and high-school 26 points; or inability to respond to verbal command);
- inability to walk independently for at least 10 minutes, with or without walking devices;
- pain or other disorders precluding their participation.
研究計画
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：処理
- 割り当て：ランダム化
- 介入モデル：並列代入
- マスキング：独身
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的：Aerobic treadmill training
Participants will receive three sessions per week over 12 weeks, in groups of 2-4 participants, by a trained physiotherapist. The duration of the sessions will be 40 minutes (5-10 minutes of warm-up/cool-down and 30 minutes of aerobic treadmill training at 60-80% of heart rate reserve). The training intensity progression will be individualized. Before and after the training, participants will remain at rest for 10-15 minutes to measure heart rate, blood pressure and peripheral oxygen saturation (SpO2). The heart rate will be measured continuously during training. Participants will be asked to report any discomfort and to not volunteer to participate in other exercise program. Device: treadmill. |
Participants will receive three sessions per week over 12 weeks, in groups of 2-4 participants, by a trained physiotherapist. The duration of the sessions will be 40 minutes (5-10 minutes of warm-up/cool-down and 30 minutes of aerobic treadmill training at 60-80% of heart rate reserve). The training intensity progression will be individualized. Before and after the training, participants will remain at rest for 10-15 minutes to measure heart rate, blood pressure and peripheral oxygen saturation (SpO2). The heart rate will be measured continuously during training. Participants will be asked to report any discomfort and to not volunteer to participate in other exercise program. Device: treadmill. |
|
偽コンパレータ：Control (overground walking)
Participants will receive three sessions per week over 12 weeks, in groups of 2-4 participants, by a trained physiotherapist.
The duration of the sessions will be 40 minutes (5-10 minutes of warm-up/cool-down and 30 minutes of comfortable walking below 40% of heart rate reserve).
Before and after the training, participants will remain at rest for 10-15 minutes to measure heart rate, blood pressure and peripheral oxygen saturation (SpO2).
The heart rate will be measured continuously.
Participants will be asked to report any discomfort and to not volunteer to participate in other exercise program.
|
Participants will receive three sessions per week over 12 weeks, in groups of 2-4 participants, by a trained physiotherapist.
The duration of the sessions will be 40 minutes (5-10 minutes of warm-up/cool-down and 30 minutes of comfortable walking below 40% of heart rate reserve).
Before and after the exercise, participants will remain at rest for 10-15 minutes to measure heart rate, blood pressure and peripheral oxygen saturation (SpO2).
The heart rate will be measured continuously.
Participants will be asked to report any discomfort and to not volunteer to participate in other exercise program
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Change from baseline in Physical activity levels - multisensor monitor
時間枠：At baseline, 12 weeks post-intervention, and at 4-week follow-up
|
Physical activity levels will be assessed by a multisensor monitor (SenseWear®, BodyMedia, Pittsburgh, USA).
|
At baseline, 12 weeks post-intervention, and at 4-week follow-up
|
|
Change from baseline in Physical activity levels - Human Activity Profile
時間枠：At baseline, 12 weeks post-intervention, and at 4-week follow-up
|
Physical activity levels will be assessed by Human Activity Profile
|
At baseline, 12 weeks post-intervention, and at 4-week follow-up
|
|
Change from baseline in sedentary behavior - multisensor monitor
時間枠：At baseline, 12 weeks post-intervention, and at 4-week follow-up
|
Sedentary behavior will be assessed by a multisensor monitor (SenseWear®, BodyMedia, Pittsburgh, USA).
|
At baseline, 12 weeks post-intervention, and at 4-week follow-up
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Change from baseline in Cardiorespiratory fitness - cardiopulmonary exercise test
時間枠：At baseline, 12 weeks post-intervention, and at 4-week follow-up
|
Cardiorespiratory fitness will be assessed by cardiopulmonary exercise test
|
At baseline, 12 weeks post-intervention, and at 4-week follow-up
|
|
Change from baseline in Endurance - six minute walk test
時間枠：At baseline, 12 weeks post-intervention, and at 4-week follow-up
|
Endurance will be assessed by six minute walk test
|
At baseline, 12 weeks post-intervention, and at 4-week follow-up
|
|
Change from baseline in Endurance - shuttle walk test
時間枠：At baseline,12 weeks post-intervention, and at 4-week follow-up
|
Endurance will be assessed by shuttle walk test
|
At baseline,12 weeks post-intervention, and at 4-week follow-up
|
|
Change from baseline in Depression - Patient Health Questionnaire (PHQ-2 and PHQ-9)
時間枠：At baseline, 12 weeks post-intervention, and at 4-week follow-up
|
Depression will be assessed by Patient Health Questionnaire (PHQ-2 and PHQ-9)
|
At baseline, 12 weeks post-intervention, and at 4-week follow-up
|
|
Change from baseline in Mobility - gait speed
時間枠：At baseline,12 weeks post-intervention, and at 4-week follow-up
|
Mobility will be assessed by gait speed
|
At baseline,12 weeks post-intervention, and at 4-week follow-up
|
|
Change from baseline in Quality of life - Stroke specific quality of life
時間枠：At baseline, 12 weeks post-intervention, and at 4-week follow-up
|
Quality of life will be assessed by Stroke specific quality of life
|
At baseline, 12 weeks post-intervention, and at 4-week follow-up
|
|
Change from baseline in Participation - Stroke impact scale
時間枠：At baseline, 12 weeks post-intervention, and at 4-week follow-up
|
Participation will be assessed by (Stroke impact scale)
|
At baseline, 12 weeks post-intervention, and at 4-week follow-up
|
協力者と研究者
捜査官
- 主任研究者：Christina Faria, Ph.D.、Federal University of Minas Gerais
出版物と役立つリンク
一般刊行物
- Saunders DH, Mead GE, Fitzsimons C, Kelly P, van Wijck F, Verschuren O, Backx K, English C. Interventions for reducing sedentary behaviour in people with stroke. Cochrane Database Syst Rev. 2021 Jun 29;6(6):CD012996. doi: 10.1002/14651858.CD012996.pub2.
- Billinger SA, Arena R, Bernhardt J, Eng JJ, Franklin BA, Johnson CM, MacKay-Lyons M, Macko RF, Mead GE, Roth EJ, Shaughnessy M, Tang A; American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Lifestyle and Cardiometabolic Health; Council on Epidemiology and Prevention; Council on Clinical Cardiology. Physical activity and exercise recommendations for stroke survivors: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014 Aug;45(8):2532-53. doi: 10.1161/STR.0000000000000022. Epub 2014 May 20.
- Pang MY, Charlesworth SA, Lau RW, Chung RC. Using aerobic exercise to improve health outcomes and quality of life in stroke: evidence-based exercise prescription recommendations. Cerebrovasc Dis. 2013;35(1):7-22. doi: 10.1159/000346075. Epub 2013 Feb 14.
- Aguiar LT, Nadeau S, Britto RR, Teixeira-Salmela LF, Martins JC, Faria CDCM. Effects of aerobic training on physical activity in people with stroke: protocol for a randomized controlled trial. Trials. 2018 Aug 17;19(1):446. doi: 10.1186/s13063-018-2823-0.
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (見積もり)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。